NCT04619875

A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects

A Randomized, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Kaleido Biosciences · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This exploratory, randomized, open label study aims to explore the safety, tolerability, pharmacokinetics, and effects of increasing intake amounts of two novel glycans on the gut microbiota of healthy subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
OTHER	KB5	KB5, a novel glycan, is a Kaleido laboratory code for KB174
OTHER	SG1	SG1 is a novel glycan
OTHER	Lactulose	Lactulose is a synthetic dissacharide

Timeline

• Start date: 2017-09-11
• Primary completion: 2017-11-21
• Completion: 2017-11-21
• First posted: 2020-11-06
• Last updated: 2020-11-06

Locations

1 site across 1 country: United States